|
STAMBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26530000002612E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.048430E-04 |
| Normal-vs-Stage2 |
1.522080E-02 |
| Normal-vs-Stage3 |
1.04299999970081E-07 |
| Normal-vs-Stage4 |
1.279610E-03 |
| Stage1-vs-Stage2 |
9.700800E-01 |
| Stage1-vs-Stage3 |
1.827680E-02 |
| Stage1-vs-Stage4 |
5.744400E-01 |
| Stage2-vs-Stage3 |
1.118800E-01 |
| Stage2-vs-Stage4 |
6.567800E-01 |
| Stage3-vs-Stage4 |
2.552800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.35710000026945E-07 |
| Normal-vs-AfricanAmerican |
1.807380E-01 |
| Normal-vs-Asian |
2.112400E-02 |
| Caucasian-vs-AfricanAmerican |
1.052610E-01 |
| Caucasian-vs-Asian |
2.357200E-01 |
| AfricanAmerican-vs-Asian |
5.466400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.7532999999913E-06 |
| Normal-vs-Female |
2.19069999999322E-05 |
| Male-vs-Female |
2.327000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.602400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.96662999999431E-05 |
| Normal-vs-Age(61-80Yrs) |
1.82210999999377E-05 |
| Normal-vs-Age(81-100Yrs) |
2.337000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.915600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.706200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.143800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.069800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.403000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.328400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.973800E-01 |
| Classical-VS-Follicular |
3.738400E-01 |
| Classical-VS-Other |
2.447800E-01 |
| Classical-VS-Normal |
1.246560E-04 |
| Tall-VS-Follicular |
3.302200E-01 |
| Tall-VS-Other |
3.574200E-01 |
| Tall-VS-Normal |
1.398580E-03 |
| Follicular-VS-Other |
2.781600E-01 |
| Follicular-VS-Normal |
2.594400E-02 |
| Other-VS-Normal |
4.121300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.58999999999776E-05 |
| Normal-vs-N1 |
3.86460000001421E-06 |
| N0-vs-N1 |
6.587800E-02 |
|
|
